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Hunting for the psoriasis gene(s) proceeds at a remarkable speed.
As in other complex disorders with immune background (e.g.,
rheumatoid arthritis, Crohn’s disease, uveitis and others), di⁄cul-
ties in dismantling the genetics exist due to their multifactorial
and multigenic nature. In psoriasis, additional problems are
caused by the observation that what was recognized as a distinct
entity more than 150 years ago now appears to consist of subtypes
according to morphology (pustular vs. nonpustular), localization,
age of onset, course and severity, as well as others (Christophers,
2001).
So far, a total of 16 potential susceptibility loci located on 14
chromosomes have been identi¢ed by genome-wide screening.
Among these, some seven suspected loci are now designated
(PSORS 1^7). By far the strongest susceptibility locus resides on
the short arm of chromosome 6 within the MHC (Capon et al,
2002). Therefore, it is more than mere coincidence that several
research groups started focusing on this region. In addition to
HLA Cw6, which was ¢rst detected as showing strong linkage
disequilibrium with psoriasis (Tiilikainen et al, 1980), especially
the early onset type, there are loci in the immediate neighborhood
that have been shown to be in strong disequilibrium.They include
HCR and Corneodesmosin (CDSN), as well as HLA-Cw6 itself
(Enfors and Molin, 1971; Asumalahti et al, 2000; Nair et al, 2000).
CDSN appears to be attractive, since this gene codes for a protein
known to be involved in keratinocyte cohesion in the peripheral
zone of epidermis. These three susceptibility loci are concentrated
within a 200kb region at the centromeric end of Class I MHC
and the allelic variants HLA-Cw6, HCRnWWCC, and CDSNn5
represent high risk alleles showing strong linkage disequilibrium.
In this well-written report in this issue of the JID, Asumalahti
and coworkers raise the question of whether subtypes such as
plaque-type psoriasis can be distinguished from guttate psoriasis
and, further, from palmo-plantar pustulosis by genotyping the
three high risk alleles mentioned.
Both clinical subtypes, plaque-type and guttate psoriasis,
demonstrated an almost identical genetic background with strong
association to PSORS1. The data, as stated by the authors, indi-
cate that phenotypical disease expression of the psoriasis subtypes
discussed here is controlled by factors not related to the PSORS1
locus.
On the other hand, palmo-plantar pustulosis, often called
pustular psoriasis of palms and soles, failed to demonstrate an
association with any of the three candidate genes studied. This
is interesting as palmo-plantar pustulosis occurs frequently in
conjunction with psoriasis (studies report around 24% of the
patients) (Enfors and Molin, 1971). Earlier serological determina-
tion also failed to demonstrate an association with HLA in
palmo-plantar pustulosis (Asumalahti et al, this issue; Rosen et al,
1982), although the methodology used in those studies di¡ers
from the genotyping used here. The data suggest that palmo-
plantar pustulosis represents a distinct genetic entity not related
to the PSORS 1 genotype.
With these data an old question appears to be answered,
namely whether pustulosis on hands and soles represents a distinct
entity on its own or merely represents a psoriasis variant modi¢ed
by region-speci¢c anatomical factors. The authors have convin-
cingly proven the latter idea to be obsolete.
As always, new questions arise, e.g., what do both conditions,
nonpustular psoriasis (plaque- and guttate-type) have in common
with pustulosis of hands and soles to generate comorbidity at
such high proportions? This question has also been raised in
other conditions showing clinical concomitance with psoriasis,
e.g., psoriatic arthritis, generalized pustular psoriasis (Zumbusch),
Reiter’s disease or Crohn’s disease. At present one may hypothe-
size that these conditions, although di¡erent in phenotypical
expression as well as by genetic make-up, are likely to share
common pathogenetic features that regulate disease expression
apart from known pathways.
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